Kraig Biocraft Laboratories Inc KBLB
Morningstar’s Analysis
1-Star Price
PREMIUM
5-Star Price
PREMIUM
Economic Moat
PREMIUM
There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible for overseeing the methodology that supports the quantitative fair value. As an employee of Morningstar, Inc., Mr. Davidson is guided by Morningstar, Inc.'s Code of Ethics and Personal Securities Trading Policy in carrying out his responsibilities. For information regarding Conflicts of Interests, click here .
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile
Kraig Biocraft Laboratories Inc is engaged in the development of high strength fibers using recombinant DNA technology mainly for commercial applications in both the specialty fiber and technical textile industries. It uses genetic engineering technologies to develop fibers with greater strength, resiliency and flexibility for use in its target markets, namely the textile, specialty fiber and technical textile industries. Its principle offering is a genetically engineered spider silk known as Monster Silk which is a composite fiber, spun by its line of transgenic silkworms. It generates the majority of its revenues from its business across the United States.
Ann Arbor, MI, 48104